Type 2 Diabetes Remission and Control in Overweight and in Mildly Obese Diabetic Patients at Long-Term Follow-Up After Biliopancreatic Diversion

Obesity Surgery
Gian Franco AdamiNicola Scopinaro

Abstract

In severely obese patients with type 2 diabetes (T2DM), the metabolic benefits after biliopancreatic diversion (BPD) are due to mechanisms independent of weight loss. Therefore, the anti-diabetic effect of BPD in overweight or mildly obese T2DM patients was investigated. Ninety T2DM patients with BMI 25-35 underwent BPD and were evaluated 1 and 5 years after the operation (follow-up rate 100 and 83%, respectively). T2DM control (Hb1Ac < 7%) and remission (Hb1Ac < 6 without antidiabetics) was observed in 86.6 and 65% of cases at 1 year and 64.0% and 26.5% at 5 years, respectively. The long-term T2DM remission was predicted by baseline BMI value. Both before BPD and throughout the follow-up period, HOMA values were similar in the metabolically successful and unsuccessful subjects, while C-peptide normalized for FBG value as a marker of beta cell mass and insulin secretion increased progressively only in the former from 1.06 ± 0.64 to 1.44 ± 1.08 mcg/l ml/dl-1 * 100 (p < 0.002). In T2DM patients with BMI of 25-35, a positive metabolic outcome is less frequent than in their counterparts with morbid obesity. In T2DM overweight patients, in spite of a short-term normalization of FBG and HbA1c levels and a well-sustained increase of i...Continue Reading

References

Aug 26, 1998·World Journal of Surgery·N ScopinaroA Simonelli
Mar 1, 2006·Diabetes Care·Robert A RitzelPeter C Butler
Jun 29, 2006·Diabetes·Caterina GuidoneGeltrude Mingrone
Dec 19, 2006·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·R N FaradjiR Alejandro
Oct 18, 2008·Diabetes, Obesity & Metabolism·A V Matveyenko, P C Butler
Mar 11, 2009·The American Journal of Medicine·Henry BuchwaldIsabella Sledge
Jun 11, 2009·Diabetes·Juris J MeierHenning Schrader
Oct 31, 2009·Diabetes Care·John B BuseM Sue Kirkman
Apr 9, 2011·Annals of Surgery·Nicola ScopinaroRenzo Cordera
Aug 10, 2012·Diabetes Care·Yoshifumi SaishoPeter C Butler
Feb 1, 2013·Annals of the New York Academy of Sciences·Gordon C Weir, Susan Bonner-Weir
May 15, 2013·The Journal of Clinical Endocrinology and Metabolism·Brenno AstiarragaEle Ferrannini
Oct 29, 2013·Current Opinion in Pharmacology·Jens Juul Holst
Apr 1, 2014·The New England Journal of Medicine·Philip R SchauerUNKNOWN STAMPEDE Investigators
Jun 11, 2014·JAMA : the Journal of the American Medical Association·Lars SjöströmLena M S Carlsson
Sep 18, 2014·The New England Journal of Medicine·Gerald I Shulman
Apr 7, 2015·Biochemical and Biophysical Research Communications·Justyna JanikiewiczAgnieszka Dobrzyn
Sep 19, 2015·Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery·Giovanni B CameriniNicola Scopinaro
Dec 3, 2015·Diabetes Care·Simona PanunziJohn B Dixon
Mar 8, 2016·Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery·Nicola ScopinaroGian Franco Adami
May 26, 2016·Diabetes Care·David E Cummings, Ricardo V Cohen
Oct 26, 2016·Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery·Jianzhong DiWeiping Jia
Jan 20, 2017·Obesity Surgery·Nicola ScopinaroRenzo Cordera
Feb 16, 2017·The New England Journal of Medicine·Philip R SchauerUNKNOWN STAMPEDE Investigators

❮ Previous
Next ❯

Citations

Jan 25, 2020·Diabetes Care·Ali AminianKamal Mahawar
Jul 4, 2020·Current Opinion in Lipidology·Zohaib IqbalHandrean Soran
Sep 5, 2019·International Journal of Environmental Research and Public Health·Dimitrios TsilingirisAlexander Kokkinos
Jan 27, 2021·Endocrinología, Diabetes Y Nutrición·Elena González ArnáizIsidoro Cano Rodríguez
Jul 17, 2021·Endocrinología, Diabetes Y Nutrición·Elena González ArnáizIsidoro Cano Rodríguez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

© 2022 Meta ULC. All rights reserved